CDEK
← All organizations

KalVista Pharmaceuticals, Ltd.

For profit

Also known as: KALVISTA | KalVista Pharmaceuticals | KalVista Pharmaceuticals, Ltd.

Phase 1Phase 2Phase 3Phase 4

Highest phase reached

Phase 3

First clinical trial

Jul 18, 2014

First marketed drug

Jul 3, 2025

Last known activity

Jun 24, 2024

Acquired by Merck on Oct 10, 2017

Timeline

2010s

  1. Jun 1, 2011

    KalVista Pharmaceuticals, Ltd.— Founded

  2. Nov 21, 2016

    Carbylan Therapeutics, Inc.— Acquired

  3. Oct 10, 2017

    Merck— Acquired By

2020s

  1. Jul 3, 2025

    sebetralstat— Marketing Organization

Drugs by trial phase (4 distinct, 14 trials)

Phase 3 (1 own, 1 via acquisition)

Phase 2 (2 own, 0 via acquisition)

Indications

Studied for

Marketed drugs (1)

Subsidiaries (1 direct, 1 total across the full acquisition tree)

Recent trials (21)

Details

Founded
Norton, GB Jun 1, 2011
Last known activity
Jun 24, 2024